S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged

EyePoint Pharmaceuticals (EYPT) Insider Trading & Ownership

$17.65
+0.15 (+0.86%)
(As of 04/19/2024 08:50 PM ET)

EyePoint Pharmaceuticals (NASDAQ:EYPT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
13.05%
Number Of
Insiders Buying
(Last 12 Months)
4
Amount Of
Insider Buying
(Last 12 Months)
$68.92 M
Number Of
Insiders Selling
(Last 12 Months)
9
Amount Of
Insider Selling
(Last 12 Months)
$49.30 M
Get EYPT Insider Trade Alerts

Want to know when executives and insiders are buying or selling EyePoint Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

EYPT Insider Buying and Selling by Quarter

EyePoint Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/2/2024David Scott JonesSVPSell209$28.49$5,954.41  
1/26/2024Dario A PaggiarinoInsiderSell49,325$25.66$1,265,679.50  
1/25/2024David Scott JonesSVPSell600$25.00$15,000.00  
1/23/2024Dario A PaggiarinoInsiderSell5,135$25.00$128,375.00  
1/23/2024David Scott JonesSVPSell900$25.00$22,500.00  
1/11/2024Cormorant Asset Management, LpMajor ShareholderBuy750,000$19.75$14,812,500.00  
1/11/2024Ye LiuDirectorSell1,910,500$19.45$37,159,225.00  
1/9/2024Cormorant Asset Management, LpMajor ShareholderBuy105,000$21.32$2,238,600.00  
1/8/2024Dario A PaggiarinoInsiderSell22,913$21.13$484,151.69  
12/13/2023Dario A PaggiarinoInsiderSell1,458$20.00$29,160.00  
12/8/2023Cormorant Asset Management, LpMajor ShareholderBuy588,235$17.00$9,999,995.00  
12/6/2023Ye LiuDirectorSell266,242$18.41$4,901,515.22  
12/4/2023Cormorant Asset Management, LpMajor ShareholderBuy1,919,057$21.82$41,873,823.74  
12/4/2023Michael Craig PineInsiderSell45,000$22.00$990,000.00  
9/1/2023Ew Healthcare Partners, L.P.Major ShareholderSell20,000$9.90$198,000.00  
8/30/2023Ew Healthcare Partners, L.P.Major ShareholderSell60,976$10.92$665,857.92  
8/28/2023Ew Healthcare Partners, L.P.Major ShareholderSell60,858$11.71$712,647.18  
8/24/2023Ew Healthcare Partners, L.P.Major ShareholderSell139,280$14.62$2,036,273.60  
8/22/2023Ew Healthcare Partners, L.P.Major ShareholderSell46,778$14.62$683,894.36  
5/30/2023Ye LiuDirectorSell1$6.00$6.00  
(Data available from 1/1/2013 forward)

EYPT Insider Trading Activity - Frequently Asked Questions

Who is on EyePoint Pharmaceuticals's Insider Roster?

The list of insiders at EyePoint Pharmaceuticals includes Cormorant Asset Management, Lp, Dario A Paggiarino, David Scott Jones, Ew Healthcare Partners, L.P., Michael Craig Pine, and Ye Liu. Learn more on insiders at EYPT.

What percentage of EyePoint Pharmaceuticals stock is owned by insiders?

13.05% of EyePoint Pharmaceuticals stock is owned by insiders. Learn more on EYPT's insider holdings.

Which EyePoint Pharmaceuticals insiders have been buying company stock?

The following insider purchased EYPT shares in the last 24 months: Cormorant Asset Management, Lp ($68,924,918.74).

How much insider buying is happening at EyePoint Pharmaceuticals?

Insiders have purchased a total of 3,362,292 EYPT shares in the last 24 months for a total of $68,924,918.74 bought.

Which EyePoint Pharmaceuticals insiders have been selling company stock?

The following insiders have sold EYPT shares in the last 24 months: Dario A Paggiarino ($1,907,366.19), David Scott Jones ($43,454.41), Ew Healthcare Partners, L.P. ($4,296,673.06), Michael Craig Pine ($990,000.00), and Ye Liu ($42,060,746.22).

How much insider selling is happening at EyePoint Pharmaceuticals?

Insiders have sold a total of 2,630,175 EyePoint Pharmaceuticals shares in the last 24 months for a total of $49,298,239.88 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:EYPT) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners